A carregar...
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy
INTRODUCTION: Gaucher disease is the first lysosomal disease to benefit from enzyme replacement therapy, thus serving as model for numerous other lysosomal diseases. Alglucerase was the first glucocerebrosidase purified from placental extracts, and this was then replaced by imiglucerase – a Chinese...
Na minha lista:
| Publicado no: | Core Evid |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5072572/ https://ncbi.nlm.nih.gov/pubmed/27790078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S93717 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|